المؤلفون: Simon Gilbody (52503), Elizabeth Littlewood (510237), Dean McMillan (628092), Carolyn A. Chew-Graham (3918428), Della Bailey (3698551), Samantha Gascoyne (6752801), Claire Sloan (6752810), Lauren Burke (6084314), Peter Coventry (789637), Suzanne Crosland (6752798), Caroline Fairhurst (3558770), Andrew Henry (9510502), Catherine Hewitt (3617465), Kalpita Joshi (11552786), Eloise Ryde (11552789), Leanne Shearsmith (9318033), Gemma Traviss-Turner (11552792), Rebecca Woodhouse (10157927), Andrew Clegg (7713461), Tom Gentry (4819110), Andrew J. Hill (7245602), Karina Lovell (52502), Sarah Dexter Smith (11552795), Judith Webster (473403), David Ekers (579120)

مصطلحات موضوعية: Medicine, Neuroscience, Pharmacology, Biotechnology, Science Policy, Mental Health, Infectious Diseases, u >< b, important secondary outcomes, coronavirus disease 2019, aged 74 years, type 2 errors, mostly white (<, 91 (− 2, 26 (− 2, 31 (− 1, 20 (− 1, shield &# 8221, 6 %) completed, 34 (− 4, 47and 3 months, 3 months 44, 2 main limitations, physical component scale, pcs )), anxiety, minimal depressive symptoms, also measured health, 7 %) randomised, ci − 2

Relation: https://figshare.com/articles/journal_contribution/Details_of_BASIL_participants_who_did_and_did_not_complete_the_BASIL_modules_and_included_in_qualitative_analysis_/16798217

الاتاحة: https://doi.org/10.1371/journal.pmed.1003779.s001

المؤلفون: Simon Gilbody (52503), Elizabeth Littlewood (510237), Dean McMillan (628092), Carolyn A. Chew-Graham (3918428), Della Bailey (3698551), Samantha Gascoyne (6752801), Claire Sloan (6752810), Lauren Burke (6084314), Peter Coventry (789637), Suzanne Crosland (6752798), Caroline Fairhurst (3558770), Andrew Henry (9510502), Catherine Hewitt (3617465), Kalpita Joshi (11552786), Eloise Ryde (11552789), Leanne Shearsmith (9318033), Gemma Traviss-Turner (11552792), Rebecca Woodhouse (10157927), Andrew Clegg (7713461), Tom Gentry (4819110), Andrew J. Hill (7245602), Karina Lovell (52502), Sarah Dexter Smith (11552795), Judith Webster (473403), David Ekers (579120)

مصطلحات موضوعية: Medicine, Neuroscience, Pharmacology, Biotechnology, Science Policy, Mental Health, Infectious Diseases, u >< b, important secondary outcomes, coronavirus disease 2019, aged 74 years, type 2 errors, mostly white (<, 91 (− 2, 26 (− 2, 31 (− 1, 20 (− 1, shield &# 8221, 6 %) completed, 34 (− 4, 47and 3 months, 3 months 44, 2 main limitations, physical component scale, pcs )), anxiety, minimal depressive symptoms, also measured health, 7 %) randomised, ci − 2

Relation: https://figshare.com/articles/journal_contribution/Details_of_BSWs_included_in_qualitative_analysis_BSW_BASIL_support_worker_/16798220

الاتاحة: https://doi.org/10.1371/journal.pmed.1003779.s002

المؤلفون: Simon Gilbody (52503), Elizabeth Littlewood (510237), Dean McMillan (628092), Carolyn A. Chew-Graham (3918428), Della Bailey (3698551), Samantha Gascoyne (6752801), Claire Sloan (6752810), Lauren Burke (6084314), Peter Coventry (789637), Suzanne Crosland (6752798), Caroline Fairhurst (3558770), Andrew Henry (9510502), Catherine Hewitt (3617465), Kalpita Joshi (11552786), Eloise Ryde (11552789), Leanne Shearsmith (9318033), Gemma Traviss-Turner (11552792), Rebecca Woodhouse (10157927), Andrew Clegg (7713461), Tom Gentry (4819110), Andrew J. Hill (7245602), Karina Lovell (52502), Sarah Dexter Smith (11552795), Judith Webster (473403), David Ekers (579120)

مصطلحات موضوعية: Medicine, Neuroscience, Pharmacology, Biotechnology, Science Policy, Mental Health, Infectious Diseases, u >< b, important secondary outcomes, coronavirus disease 2019, aged 74 years, type 2 errors, mostly white (<, 91 (− 2, 26 (− 2, 31 (− 1, 20 (− 1, shield &# 8221, 6 %) completed, 34 (− 4, 47and 3 months, 3 months 44, 2 main limitations, physical component scale, pcs )), anxiety, minimal depressive symptoms, also measured health, 7 %) randomised, ci − 2

Relation: https://figshare.com/articles/journal_contribution/SAP_/16798226

الاتاحة: https://doi.org/10.1371/journal.pmed.1003779.s003

المؤلفون: Simon Gilbody (52503), Elizabeth Littlewood (510237), Dean McMillan (628092), Carolyn A. Chew-Graham (3918428), Della Bailey (3698551), Samantha Gascoyne (6752801), Claire Sloan (6752810), Lauren Burke (6084314), Peter Coventry (789637), Suzanne Crosland (6752798), Caroline Fairhurst (3558770), Andrew Henry (9510502), Catherine Hewitt (3617465), Kalpita Joshi (11552786), Eloise Ryde (11552789), Leanne Shearsmith (9318033), Gemma Traviss-Turner (11552792), Rebecca Woodhouse (10157927), Andrew Clegg (7713461), Tom Gentry (4819110), Andrew J. Hill (7245602), Karina Lovell (52502), Sarah Dexter Smith (11552795), Judith Webster (473403), David Ekers (579120)

مصطلحات موضوعية: Medicine, Neuroscience, Pharmacology, Biotechnology, Science Policy, Mental Health, Infectious Diseases, u >< b, important secondary outcomes, coronavirus disease 2019, aged 74 years, type 2 errors, mostly white (<, 91 (− 2, 26 (− 2, 31 (− 1, 20 (− 1, shield &# 8221, 6 %) completed, 34 (− 4, 47and 3 months, 3 months 44, 2 main limitations, physical component scale, pcs )), anxiety, minimal depressive symptoms, also measured health, 7 %) randomised, ci − 2

Relation: https://figshare.com/articles/journal_contribution/CONSORT_checklist_/16798229

الاتاحة: https://doi.org/10.1371/journal.pmed.1003779.s004

المؤلفون: Simon Gilbody (52503), Elizabeth Littlewood (510237), Dean McMillan (628092), Carolyn A. Chew-Graham (3918428), Della Bailey (3698551), Samantha Gascoyne (6752801), Claire Sloan (6752810), Lauren Burke (6084314), Peter Coventry (789637), Suzanne Crosland (6752798), Caroline Fairhurst (3558770), Andrew Henry (9510502), Catherine Hewitt (3617465), Kalpita Joshi (11552786), Eloise Ryde (11552789), Leanne Shearsmith (9318033), Gemma Traviss-Turner (11552792), Rebecca Woodhouse (10157927), Andrew Clegg (7713461), Tom Gentry (4819110), Andrew J. Hill (7245602), Karina Lovell (52502), Sarah Dexter Smith (11552795), Judith Webster (473403), David Ekers (579120)

مصطلحات موضوعية: Medicine, Neuroscience, Pharmacology, Biotechnology, Science Policy, Mental Health, Infectious Diseases, u >< b, important secondary outcomes, coronavirus disease 2019, aged 74 years, type 2 errors, mostly white (<, 91 (− 2, 26 (− 2, 31 (− 1, 20 (− 1, shield &# 8221, 6 %) completed, 34 (− 4, 47and 3 months, 3 months 44, 2 main limitations, physical component scale, pcs )), anxiety, minimal depressive symptoms, also measured health, 7 %) randomised, ci − 2

Relation: https://figshare.com/articles/figure/CONSORT_flow_diagram_/16798232

الاتاحة: https://doi.org/10.1371/journal.pmed.1003779.g001

المؤلفون: Simon Gilbody (52503), Elizabeth Littlewood (510237), Dean McMillan (628092), Carolyn A. Chew-Graham (3918428), Della Bailey (3698551), Samantha Gascoyne (6752801), Claire Sloan (6752810), Lauren Burke (6084314), Peter Coventry (789637), Suzanne Crosland (6752798), Caroline Fairhurst (3558770), Andrew Henry (9510502), Catherine Hewitt (3617465), Kalpita Joshi (11552786), Eloise Ryde (11552789), Leanne Shearsmith (9318033), Gemma Traviss-Turner (11552792), Rebecca Woodhouse (10157927), Andrew Clegg (7713461), Tom Gentry (4819110), Andrew J. Hill (7245602), Karina Lovell (52502), Sarah Dexter Smith (11552795), Judith Webster (473403), David Ekers (579120)

مصطلحات موضوعية: Medicine, Neuroscience, Pharmacology, Biotechnology, Science Policy, Mental Health, Infectious Diseases, u >< b, important secondary outcomes, coronavirus disease 2019, aged 74 years, type 2 errors, mostly white (<, 91 (− 2, 26 (− 2, 31 (− 1, 20 (− 1, shield &# 8221, 6 %) completed, 34 (− 4, 47and 3 months, 3 months 44, 2 main limitations, physical component scale, pcs )), anxiety, minimal depressive symptoms, also measured health, 7 %) randomised, ci − 2

Relation: https://figshare.com/articles/dataset/Baseline_demographics_of_participants_as_randomised_/16798235

الاتاحة: https://doi.org/10.1371/journal.pmed.1003779.t001

المؤلفون: Simon Gilbody (52503), Elizabeth Littlewood (510237), Dean McMillan (628092), Carolyn A. Chew-Graham (3918428), Della Bailey (3698551), Samantha Gascoyne (6752801), Claire Sloan (6752810), Lauren Burke (6084314), Peter Coventry (789637), Suzanne Crosland (6752798), Caroline Fairhurst (3558770), Andrew Henry (9510502), Catherine Hewitt (3617465), Kalpita Joshi (11552786), Eloise Ryde (11552789), Leanne Shearsmith (9318033), Gemma Traviss-Turner (11552792), Rebecca Woodhouse (10157927), Andrew Clegg (7713461), Tom Gentry (4819110), Andrew J. Hill (7245602), Karina Lovell (52502), Sarah Dexter Smith (11552795), Judith Webster (473403), David Ekers (579120)

مصطلحات موضوعية: Medicine, Neuroscience, Pharmacology, Biotechnology, Science Policy, Mental Health, Infectious Diseases, u >< b, important secondary outcomes, coronavirus disease 2019, aged 74 years, type 2 errors, mostly white (<, 91 (− 2, 26 (− 2, 31 (− 1, 20 (− 1, shield &# 8221, 6 %) completed, 34 (− 4, 47and 3 months, 3 months 44, 2 main limitations, physical component scale, pcs )), anxiety, minimal depressive symptoms, also measured health, 7 %) randomised, ci − 2

Relation: https://figshare.com/articles/dataset/Patient-reported_outcome_measures_/16798238

الاتاحة: https://doi.org/10.1371/journal.pmed.1003779.t002

المؤلفون: Simon Gilbody (52503), Elizabeth Littlewood (510237), Dean McMillan (628092), Carolyn A. Chew-Graham (3918428), Della Bailey (3698551), Samantha Gascoyne (6752801), Claire Sloan (6752810), Lauren Burke (6084314), Peter Coventry (789637), Suzanne Crosland (6752798), Caroline Fairhurst (3558770), Andrew Henry (9510502), Catherine Hewitt (3617465), Kalpita Joshi (11552786), Eloise Ryde (11552789), Leanne Shearsmith (9318033), Gemma Traviss-Turner (11552792), Rebecca Woodhouse (10157927), Andrew Clegg (7713461), Tom Gentry (4819110), Andrew J. Hill (7245602), Karina Lovell (52502), Sarah Dexter Smith (11552795), Judith Webster (473403), David Ekers (579120)

مصطلحات موضوعية: Medicine, Neuroscience, Pharmacology, Biotechnology, Science Policy, Mental Health, Infectious Diseases, u >< b, important secondary outcomes, coronavirus disease 2019, aged 74 years, type 2 errors, mostly white (<, 91 (− 2, 26 (− 2, 31 (− 1, 20 (− 1, shield &# 8221, 6 %) completed, 34 (− 4, 47and 3 months, 3 months 44, 2 main limitations, physical component scale, pcs )), anxiety, minimal depressive symptoms, also measured health, 7 %) randomised, ci − 2

Relation: https://figshare.com/articles/dataset/Unadjusted_and_AMD_between_groups_at_1_and_3_months_for_primary_and_secondary_outcomes_measure_/16798241

الاتاحة: https://doi.org/10.1371/journal.pmed.1003779.t003